We are live on ! Find out more
WINT

Windtree Therapeutics Inc

Delisted

WINT was delisted on the 4th of May, 2017.

67 hedge funds and large institutions have $93.5M invested in Windtree Therapeutics Inc in 2014 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 20 increasing their positions, 13 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

79% more call options, than puts

Call options by funds: $828K | Put options by funds: $462K

54% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 13

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

8% less funds holding

Funds holding: 7367 (-6)

20% less capital invested

Capital invested by funds: $117M → $93.5M (-$23.1M)

40% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 15

Holders
67
Holders Change
-6
Holders Change %
-8.22%
% of All Funds
1.92%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
9
Increased
20
Reduced
13
Closed
15
Calls
$828K
Puts
$462K
Net Calls
+$366K
Net Calls Change
+$113K
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$22.7M +$97.3K +3,807 +0.4%
BC
2
Broadfin Capital
New York
$14.4M
DCM
3
DAFNA Capital Management
California
$10.1M
DM
4
Deerfield Management
New York
$6.51M
BBA
5
Baker Bros. Advisors
New York
$6.5M
BIT
6
BlackRock Institutional Trust
California
$4.21M +$259K +10,127 +6%
Wellington Management Group
7
Wellington Management Group
Massachusetts
$3.82M
Vanguard Group
8
Vanguard Group
Pennsylvania
$3.57M +$19.3K +756 +0.5%
Alyeska Investment Group
9
Alyeska Investment Group
Illinois
$3.48M +$269K +10,504 +8%
Millennium Management
10
Millennium Management
New York
$3.12M +$573K +22,400 +22%
TCM
11
Tamarack Capital Management
California
$2.77M +$913K +35,714 +50%
Deutsche Bank
12
Deutsche Bank
Germany
$1.65M -$111K -4,330 -6%
NC
13
Northpointe Capital
Michigan
$1.34M +$83.8K +3,278 +7%
TI
14
Turner Investments
Pennsylvania
$931K -$510K -19,970 -35%
SFM
15
Sphera Funds Management
Israel
$890K
IMS
16
Index Management Solutions
Pennsylvania
$812K +$247K +9,672 +42%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$780K +$82.4K +3,224 +11%
COPPSERS
18
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$741K +$45.7K +1,786 +6%
Susquehanna International Group
19
Susquehanna International Group
Pennsylvania
$697K +$111K +4,355 +18%
D.E. Shaw & Co
20
D.E. Shaw & Co
New York
$595K -$25.7K -1,006 -4%
SM
21
Sabby Management
Florida
$562K +$7.29K +285 +1%
BFA
22
BlackRock Fund Advisors
California
$466K +$13.7K +535 +3%
Northern Trust
23
Northern Trust
Illinois
$326K +$42.6K +1,668 +15%
California Public Employees Retirement System
24
California Public Employees Retirement System
California
$302K
Goldman Sachs
25
Goldman Sachs
New York
$246K +$69.4K +2,714 +38%

WINT Hedge Fund Activity: Q2 2014 in Review

67 of the 3,481 institutional investors tracked by Wall St. Rank reported a position in Windtree Therapeutics Inc (WINT) for Q2 2014, worth a combined $93.5M — down 20% from $117M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of WINT and 9 opened new positions — a net loss of 6 holders — while 13 trimmed existing stakes and 20 added.

The largest buyer was Tamarack Capital Management, adding an estimated $913K. The largest seller was Wells Fargo, cutting an estimated $2.12M.

  • 67 institutional investors held Windtree Therapeutics Inc (WINT) as of Q2 2014, down from 73 in Q1 2014.
  • Funds reported $93.5M of Windtree Therapeutics Inc stock for Q2 2014, down 20% quarter-over-quarter.
  • 9 funds opened new Windtree Therapeutics Inc positions in Q2 2014 and 15 closed out, a net change of -6 holders.
  • The largest Windtree Therapeutics Inc buyer in Q2 2014 was Tamarack Capital Management, an estimated $913K added.
  • The largest Windtree Therapeutics Inc seller in Q2 2014 was Wells Fargo, an estimated $2.12M sold.

Based on aggregated 13F filings for Q2 2014.